Featured

26-27 September 2022

ISMPP West 2022

Oxford PharmaGenesis is proud to sponsor ISMPP West 2022. On this page you can find information about our award-winning work and white papers, leaflets and more.

We are an independent, global HealthScience consultancy. We help clients to take their publications further with a range of transformative services. Our team use innovative approaches to explore new frontiers in publications, strategic medical communications, informatics and data science, patient engagement, e-learning, open access and value demonstration.

All
Show
  • All
  • News
  • Articles
  • Events

Oxford PharmaGenesis to present pioneering data source assessment method at ISPOR

A pioneering method to identify and recommend bespoke data sources for global programmes of real-world evidence is being presented at ISPOR’s 19th Annual International Meeting in Montreal, Canada (31 May–4 June 2014).

HealthScience to be showcased at ISPOR

Oxford PharmaGenesis™ will be showcasing its new HealthScience approach to demonstrating product value and achieving market access at ISPOR’s 19th Annual International Meeting in Montreal, Canada (31 May–4 June 2014).

Meet Oxford PharmaGenesis, the HealthScience Communicators, at ISPOR in Montreal, 31 May–3 June

Oxford PharmaGenesis Value Demonstration Practice is proud to be an exhibitor once again at this year’s ISPOR International Meeting in Montreal, Canada.

Oxford PharmaGenesis launches new HealthScience approach to medical choices

Leading independent consultancy Oxford PharmaGenesis is pioneering the innovative discipline of HealthScience. For the first time, this integrates the clinical and scientific dimensions of healthcare with the economic, social, behavioural and political perspectives that determine the value of new medicines and health interventions.

Heart failure: a call to raise awareness and save lives

Addressing heart failure must be considered a global health priority because poor awareness of the disease leads to many premature deaths. Approximately 26 million people are living with heart failure worldwide, and if current trends continue the disease will impose ever-increasing burdens on patients, caregivers and healthcare systems.

Oxford PharmaGenesis welcomes investment in biosciences in Oxfordshire

Recent announcements regarding Government investments in Oxfordshire are good news for those working within biosciences in the county.